Le Lézard

News by subject: TRI

1 2 3 4 5 6 7 8 9 10

Today

06:03
Harbour BioMed ("HBM", HKEX: 02142) today announced the dosing of the first patient in its part 2 of phase I (phase Ib/IIa) clinical study of its next-generation anti-CTLA-4 antibody, where Australian patients with metastatic or advanced melanoma,...


10 may 2021

16:07
Pharmazz, Inc., a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care. The Company is marketing Centhaquine Citrate, with the brand name Lyfaquin® to health care professionals in...

15:58
Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, will be providing an update on the clinical development of rodatristat ethyl, the company's lead candidate for the...

12:08
Arthrosi Therapeutics, Inc, a pharmaceutical company founded in 2018 by a team of well-established experts in drug development, announced the first blockbuster-potential molecule, AR882, to treat gout. It will be the first small molecule that...

11:21
Camurus announces today the publication in JAMA Network Open of results from a 24-week, randomized, controlled trial (DEBUT) comparing patient reported outcomes of opioid dependence treatment with subcutaneous weekly and monthly buprenorphine depot...

11:00
In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits....

10:53
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces positive results achieved by San Marino in the fight against coronavirus thanks to the Russian Sputnik V vaccine with infection rate having fallen to zero level. This...

09:15
Ampio Pharmaceuticals , a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced that it has received Investigational...

09:12
Novavax, Inc. , a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from a preclinical study of the company's combination quadrivalent seasonal flu vaccine (NanoFlutm) and...

09:11
Cantargia AB today presented new results on the antibody CAN10 at the annual meeting of the American Association of Immunologists (AAI), Virtual IMMUNOLOGY 2021. These data demonstrate that the interleukin-1 receptor accessory protein...

09:00
Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is pleased to announce the Emergency Use Authorization of QUANTA Flash SARS-CoV-2 IgG by the US Food and Drug Administration (FDA)...

09:00
A white paper recently published by Ripple Science revealed that its flagship product, Ripple, empowered its customers to achieve >96% retention across all trials and 99% retention in 78.2% of completed trials, far outpacing industry averages....

09:00
Therapeutic Solutions International, Inc., , and its subsidiary Campbell Neurosciences announced today new data covered by its previously filed patents supporting the use of mesenchymal based stem cell therapy for schizophrenia.  Using an...

08:36
Puregraft (PG) LLC, a wholly owned subsidiary of Bimini Health Tech, announced today the publication of a clinical study demonstrating Puregraft fat grafting significantly improved knee functional status and symptom relief at 3 and 6 months, in...

08:30
Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that the first patient has been enrolled in DOORwaY-90, a study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using...

08:30
Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the publication of 24-month results from the prospective, multicenter,...

08:30
Aeglea BioTherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today reported its first quarter 2021 financial results, and provided...

08:00
INOVIO , a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced positive safety, tolerability and...

08:00
Irish based cell engineering company, Avectas today announces the publication of 'A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications' in leading international cell and...

08:00
PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Research...

07:55
Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that Catalyst Clinical Research will enter into a partnership with Calyx to leverage Calyx's...

07:50
MedShape, Inc., recently acquired by DJO® as well as the orthopedic industry leader in promoting active, adaptive healing technologies, and CurveBeam, the leader in weight-bearing CT (WBCT) imaging, jointly announced today the initiation of a new...

07:30
FluroTech Ltd. and wholly owned subsidiary FluroTest Diagnostics Systems  ("FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces the...

07:00
Bio-Techne Corporation today announced that Asuragen, a Bio-Techne brand, and scientific collaborators have published the results of a multisite evaluation study of the AmplideX® PCR/CE SMA Plus* Kit that validates its performance in delivering...

07:00
Objective Acuity ("OAL") today announced the completion of a pilot study using OAL's threshold visual acuity test for young children diagnosed with late-infantile neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a form of Batten disease. A...

07:00
Compugen Ltd. , a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has expanded its research collaboration with Johns Hopkins University to include studies investigating the biology of a...

07:00
TomaTech, Ltd., announces a major advancement in the fight against the Tomato Brown Rugose Fruit Virus (ToBRFV), which has caused significant economic damage estimated as much as billions of USD in the last few years globally. Lead by Assaf Eybishitz...

07:00
The Infectious Disease Research Institute (IDRI), Duke Human Vaccine Institute, and 3M have collaborated to create a vaccine candidate with potential to provide protection against multiple variants of SARS-CoV-2, as well as other coronaviruses. ...

06:00
IDEAYA Biosciences, Inc. , a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the first quarter ended...

06:00
IDEAYA Biosciences, Inc. , a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced dose expansion of the ongoing Phase 1/2 study (ClinicalTrials.gov Identifier:...

06:00
Bionomics Limited (Bionomics or Company), a global, clinical stage...

03:00
Irish based cell engineering company, Avectas today announces the publication of 'A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications' in leading international cell and...

02:15
BELKIN Laser, the Israel-based start-up bringing a fast, automated and non-invasive glaucoma laser treatment to market announced today that it has completed enrollment in its GLAUrious randomized controlled trial. In this confirmatory, prospective,...


7 may 2021

10:00
Pink Luminous Breast (PLB) is continuing to make strides in breast cancer awareness with a new clinical study released exploring the potential recommendation of the device to be used for routine breast screenings in non-clinical settings. The PLB...

08:00
Researchers have finally cracked the code of a bewildering pediatric disease that sets off a characteristic cytokine storm?a harmful immune system overaction resembling one that arises in COVID-19 cases?and can lead to catastrophic multisystem organ...

06:17
LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular damage and diseases, today announced research investigators lead by Drs. Hakan Kaymak, Inken Becker and Hartmut Schwahn, from the...

06:00
photonamic GmbH & Co. KG (Head office: Pinneberg, Germany; CEO: Ulrich Kosciessa, Ph.D.) ("photonamic"), a subsidiary of SBI Holdings, Inc. (Head office: Minato-ku, Tokyo; Representative Director, President and CEO: Yoshitaka Kitao) the leader in the...


6 may 2021

16:23
EVERSANA, a pioneer of next generation services to the global life sciences industry, today congratulated its partner, Humanigen, on the publication of positive results from the lenzilumab LIVE-AIR Phase 3 study in newly hospitalized COVID-19...

16:00
Robert Farber, DPM of San Antonio Podiatry Associates, performed the first two surgeries utilizing the Trigon® Osteotomy Wedge system developed by San Antonio-based Nvision Biomedical Technologies at the CHRISTUS Santa Rosa Hospital ? Westover Hills....

12:26
BELKIN Laser, the Israel-based start-up bringing a fast, automated and non-invasive glaucoma laser treatment to market announced today that it has completed enrollment in its GLAUrious randomized controlled trial. In this confirmatory, prospective,...

11:38
Oncologists at University Hospitals (UH) have two new powerful tools in the fight against cancer following the announcement that Abecma & Breyanzi, from Bristol Myers Squibb (BMS), are currently being used to treat patients at UH Seidman Cancer...

10:53
Cantargia AB today announced signing a Letter of Intent with the Spanish Breast Cancer Group (GEICAM) to perform a new clinical trial investigating the antibody nadunolimab (CAN04) in combination with carboplatin/gemcitabine for the treatment of...

09:00
Abbott today announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AFib) and heart failure. The first-of-its-kind trial aims to provide new insights into more effective treatment for...

08:30
Nova Mentis Life Science Corp. ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders, is pleased to announce that its...

08:30
AcelRx Pharmaceuticals, Inc. , (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced an investigator-initiated study to be...

08:30
Asieris Pharmaceuticals ("Asieris") and BeiGene, Ltd. ("BeiGene") today announced that they have entered into a clinical collaboration agreement to evaluate the safety and efficacy of oral APL-1202 in combination with tislelizumab as neoadjuvant...

08:25
Small business, Evon Medics, LLC today announced that its study titled "Comparative Effects of Repetitive Odor Identification and Odor Memory Tasks on Olfactory Engagement in Older Populations ? A Pilot fMRI Study" has been published in the Dove...

08:20
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that it has entered into a clinical trial collaboration with a subsidiary of Merck...

08:17
Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases, today announced that 50% of patients have been enrolled and randomized in the Phase II clinical trial...

08:12
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V ? the world's first registered vaccine against coronavirus. The single dose Sputnik Light vaccine demonstrated 79.4% efficacy according to...

1 2 3 4 5 6 7 8 9 10